These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17868433)

  • 61. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Newborn hepatitis B vaccination coverage among children born January 2003-June 2005--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(30):825-8. PubMed ID: 18668021
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Inoculation rates of children starting school in Bavaria].
    Morlock G; Arenz S; Wildner M
    MMW Fortschr Med; 2005 Feb; 147(8):41, 43-4. PubMed ID: 18441564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Epidemiological characteristics and prevention strategies of viral hepatitis in Chongwen District of Beijing during 1997-2006].
    Wang LJ; Zhou Y; Hu YQ; Chang ZR
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Aug; 42(8):592-5. PubMed ID: 19115624
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of hepato-tropic viral infections.
    Shah HA
    Trop Gastroenterol; 1994; 15(2):55-63. PubMed ID: 7831719
    [No Abstract]   [Full Text] [Related]  

  • 66. Response to booster hepatitis B vaccines in liver-transplanted children primarily vaccinated in infancy.
    Ni YH; Ho MC; Wu JF; Chen HL; Wu YM; Hu RH; Lee PH; Chang MH
    Transplantation; 2008 Dec; 86(11):1531-5. PubMed ID: 19077885
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
    Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Universal childhood immunization against hepatitis A: whoa!
    Takayama JI
    West J Med; 1999 Jun; 170(6):325-6. PubMed ID: 10443157
    [No Abstract]   [Full Text] [Related]  

  • 72. Viral hepatitis. From prevention to antivirals.
    Jonas MM
    Clin Liver Dis; 2000 Nov; 4(4):849-77. PubMed ID: 11232361
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The prevention of viral hepatitis.
    Krugman S
    Ann Clin Res; 1976 Jun; 8(3):216-20. PubMed ID: 63266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Know the ABCs of viral hepatitis.
    Posit Aware; 1999; 10(3):63. PubMed ID: 11366773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Infectious diseases and the immunizations of today and tomorrow.
    Selekman J
    Pediatr Nurs; 1998; 24(4):309-15. PubMed ID: 9849263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Viral hepatitis.
    Mitchell GW; Maniscalco PM; West KH; Dunn S
    Emerg Med Serv; 1990 Mar; 19(3):36-43. PubMed ID: 10104086
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 78. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):997-1001. PubMed ID: 19763075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis vaccines.
    Koff RS
    Infect Dis Clin North Am; 2001 Mar; 15(1):83-95. PubMed ID: 11301824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.